๐ฐ Loss Attributable News
Page 6 - Loss Attributable News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Loss Attributable. Real-time updates on events, politics, business and more.
December 19, 2023
Managements Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Changes of the 2022 Form 10-K. The following discussion...
December 12, 2023
TROY, Mich., Dec. 12, 2023 -- Agrify Corporation , a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced financial results for the second...
November 28, 2023
Ending ARR surpasses $3 billion milestone, growing 35% year-over-year to reach $3.15 billion Record net new ARR of $223 million driven by accelerating year-over-year growth Delivers record...
November 25, 2023
— First Half Revenue of $84.4 million, down 15.9% year-over-year —— First Half GMV of $115.5 million, down 20.6% year-over-year — SHANGHAI, Nov. 24, 2023 /PRNewswire/ —ย Jowell Global Ltd. (“Jowell” or the “Company”) (NASDAQ: JWEL), one of the leading cosmetics, health and nutritional supplements, and household products e-commerce platforms in China, today announced its unaudited […]
November 24, 2023
/PRNewswire/ -- Jowell Global Ltd. ("Jowell" or the "Company") (NASDAQ: JWEL), one of the leading cosmetics, health and nutritional supplements, and household...
November 22, 2023
/PRNewswire/ -- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"), a leading integrated smart supply chain solutions and logistics services provider in China...
November 22, 2023
HANGZHOU, China, Nov. 22, 2023 /PRNewswire/ -- BEST Inc. (NYSE: BEST) (BEST or the Company), a leading integrated smart supply chain solutions...
November 21, 2023
Table of Contents WeWork Inc. THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 TABLE OF CONTENTS ...
November 17, 2023
/PRNewswire/ -- BIT Mining Limited (NYSE: BTCM) ("BIT Mining," "the Company," "we," "us," or "our company"), a leading technology-driven cryptocurrency mining...
November 14, 2023
- VIRAGE, the Phase 2b clinical trial of VCN-01 in combination with chemotherapy for metastatic Pancreatic Ductal Adenocarcinoma remains on track ...